Skip to content

Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification

Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification:a Multicenter, Endoscopist-blinded Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04582942
Enrollment
2028
Registered
2020-10-12
Start date
2020-08-06
Completion date
2021-08-15
Last updated
2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation Before Colonoscopy

Keywords

Colonoscopy, Lactulose, Polyethylene glycol, Bowel preparation

Brief summary

The purpose of this study is to evaluate the efficacy of polyethylene glycol(PEG) combined with lactulose for bowel preparation before colonoscopy in low-risk patients and high-risk patients.

Detailed description

The quality of bowel preparation is crucial for colonoscopy. Some high-risk factors for inadequate bowel preparation have been identified , including age \>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) \>25, use of tricyclic antidepressant or narcotics. Patients were considered as high risk if they have any of the above factors and considered as low risk if they did not have any of these risk factors.This is a multicenter, endoscopist-blinded study to compare the efficacy of PEG combined with lactulose and PEG alone in bowel preparation. In colonoscopy procedures, endoscopists who were blinded to the intervention evaluated the overall quality of colonoscopy cleaning according to the Boston Bowel Preparation Scale. Patients' tolerance, defecation, adverse events and adenoma detection rate (ADR) were also evaluated.

Interventions

DRUGPEG

Patients began to drink 1 L of PEG at 8:00 PM on the day before colonoscopy at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took the remaining 2 L of PEG 4-6 hours before colonoscopy.

On the day before colonoscopy , Patients took 45 mL lactulose solution at 7:00 PM. And then Patients began to drink 1 L of PEG at 8:00 PM at a rate of 250 mL every 10- 15 minutes. On the day of the procedure, patients took 45 mL lactulose solution and the remaining 2 L of PEG 4-6 hours before colonoscopy.

Sponsors

Hubei Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Wuhan Central Hospital
CollaboratorOTHER
Wuhan Third Hospital
CollaboratorOTHER
The General Hospital of Central Theater Command
CollaboratorOTHER
The Third People's Hospital of Hubei Province
CollaboratorOTHER
Wuhan Puren Hospital
CollaboratorOTHER
Wuhan Puai Hospital
CollaboratorUNKNOWN
Tian You Hospital Affiliated to Wuhan University of Science and Technology
CollaboratorUNKNOWN
Wuhan Red Cross Hospital
CollaboratorUNKNOWN
Renmin Hospital of Wuhan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Investigator)

Masking description

The allocation assignment of patients was performed by a designated technician at each center based on a computer-generated random sequence. The designated technician was not involved in the colonoscopy procedure.

Intervention model description

Patients scheduled for colonoscopy were stratified into low- and high-risk patients based on the inclusion criteria. Low- and high-risk patients were randomized to the PEG alone or lactulose combined with PEG group respectively.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Adults undergoing colonoscopy.

Exclusion criteria

* 1.presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc); * 2.Patients with galactosemia; * 3\. hypersensitivity to any of the ingredients; * 4.Pregnancy or lactation; * 5.Use of lactulose,prokinetic agents or purgatives within 7 days; * 6.Unwilling to sign informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Boston Bowel Preparation Scaleduring colonoscopyCleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2, we regard it as adequate bowel preparation.

Secondary

MeasureTime frameDescription
Rate of adverse events2 daysadverse events, such as vomiting, nausea, headache, abdominal distention,abdominal pain.
Cecal intubation rateduring colonoscopyColonoscopy reaches cecal region.
Cecal intubation timeduring colonoscopyColonoscopy reaches cecal region.
Adenoma Detection Rate2 daysDiagnosis was confirmed by histologic examination
defecation frequency2 daysFrequency of bowel movement.
Willingness to repeat bowel preparation2 daysThe number of patients have a willingness to undergo a repeated bowel preparation if needed.
Withdrawal timeduring colonoscopyThe time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026